Skip to content
The Nexus
HEALTHMay 31 · 15:08 UTCCBS NEWS

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

A new drug called daraxonrasib is nearly doubling survival rates in some pancreatic cancer patients, according to a study. The medication is helping people with advanced pancreatic cancer live longer.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
daraxonrasibtopicpancreatic cancertopicadvanced pancreatic cancertopicsurvival ratestopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting